Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FACTOR-XA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 975 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Weber, N; Wendel, HP; Ziemer, G
      Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption

      BIOMATERIALS
    2. Steinmetzer, T; Schweinitz, A; Kunzel, S; Wikstrom, P; Hauptmann, J; Sturzebecher, J
      Structure-activity relationships of new NAPAP-analogs

      JOURNAL OF ENZYME INHIBITION
    3. Clare, BW; Scozzafava, A; Supuran, CT
      Protease inhibitors, part 13: Specific, weakly basic thrombin inhibitors incorporating sulfonyl dicyandiamide moieties in their structure

      JOURNAL OF ENZYME INHIBITION
    4. Owens, TD; Semple, JE
      Atom-economical synthesis of the N(10)-C(17) fragment of cyclotheonamides via a novel passerini reaction-deprotection-acyl migration strategy

      ORGANIC LETTERS
    5. Grimm, DR; Colter, MB; Braunschweig, M; Alexander, LJ; Neame, PJ; Kim, HKW
      Porcine factor V: cDNA cloning, gene mapping, three-dimensional protein modeling of membrane binding sites and comparative anatomy of domains

      CELLULAR AND MOLECULAR LIFE SCIENCES
    6. Betz, A
      Recent advances in Factor Xa inhibitors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    7. Coburn, CA
      Small-molecule direct thrombin inhibitors: 1997-2000

      EXPERT OPINION ON THERAPEUTIC PATENTS
    8. Ibrahim, MA; Ghazy, AHM; Maharem, TM; Khalil, MI
      Factor Xa (FXa) inhibitor from the nymphs of the camel tick Hyalomma dromedarii

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    9. Chan, JCY
      Gene targeting in hemostasis. Tissue factor pathway inhibitor

      FRONTIERS IN BIOSCIENCE
    10. Fossler, MJ; Barrett, JS; Hainer, JW; Riddle, JG; Ostegaard, P; van der Elst, E; Sprogel, P
      Pharmacodynamics of intravenous and subcutaneous tinzaparin and heparin inhealthy volunteers

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    11. Bouchard, BA; Tracy, PB
      Platelets, leukocytes, and coagulation

      CURRENT OPINION IN HEMATOLOGY
    12. Zega, A; Mlinsek, G; Sepic, P; Grdadolnik, SG; Solmajer, T; Tschopp, TB; Steiner, B; Kikelj, D; Urleb, U
      Design and structure-activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: Potency and selectivity enhancements via P2 optimization

      BIOORGANIC & MEDICINAL CHEMISTRY
    13. Amino, R; Tanaka, AS; Schenkman, S
      Triapsin, an unusual activatable serine protease from the saliva of the hematophagous vector of Chagas' disease Triatoma infestans (Hemiptera : Reduviidae)

      INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
    14. Levesque, S; St-Denis, Y; Bachand, B; Preveille, P; Leblond, L; Winocour, PD; Edmunds, JJ; Rubin, JR; Siddiqui, MA
      Novel bicyclic lactam inhibitors of thrombin: Potency and selectivity optimization through P1 residues

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    15. Heinelt, U; Herok, S; Matter, H; Wildgoose, P
      Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    16. Young, WB; Kolesnikov, A; Rai, R; Sprengeler, PA; Leahy, EM; Shrader, WD; Sangalang, J; Burgess-Henry, J; Spencer, J; Elrod, K; Cregar, L
      Optimization of a screening lead for factor VIIa/TF

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    17. Moatti, D; Meirhaeghe, A; Ollivier, V; Bauters, C; Amouyel, P; de Prost, D
      Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty

      BLOOD COAGULATION & FIBRINOLYSIS
    18. Rai, R; Sprengeler, PA; Elrod, KC; Young, WB
      Perspectives on factor Xa inhibition

      CURRENT MEDICINAL CHEMISTRY
    19. Weitz, JI
      New anticoagulant drugs

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    20. Chi, LG; Mertz, TE; Rogers, KL; Janiczek, N; Peng, YW; Saganek, L; Bousley, RF; Juneau, PL; Uprichard, ACG; Gallagher, KP
      Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: Comparison with inogatran

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    21. Makino, S; Kayahara, T; Tashiro, K; Takahashi, M; Tsuji, T; Shoji, M
      Discovery of a novel serine protease inhibitor utilizing a structure-basedand experimental selection of fragments technique

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    22. Rester, U; Bode, W; Sampaio, CAM; Auerswald, EA; Lopes, APY
      Cloning, purification, crystallization and preliminary X-ray diffraction analysis of the antistasin-type inhibitor ghilanten (domain I) from Haementeria ghilianii in complex with porcine beta-trypsin

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    23. Sun, LB; Utoh, J; Moriyama, S; Tagami, H; Okamoto, K; Kitamura, N
      Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits

      JOURNAL OF VASCULAR SURGERY
    24. Blanc-Brude, OP; Chambers, RC; Leoni, P; Dik, WA; Laurent, GJ
      Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    25. Guilford, WJ; Dallas, J; Arnaiz, D
      Synthesis of C-13(3), N-15(4)-labeled factor Xa inhibitor

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    26. Persson, KEM; Hillarp, A; Dahlback, B
      Analytical considerations for free protein S assays in protein S deficiency

      THROMBOSIS AND HAEMOSTASIS
    27. Bajaj, MS; Birktoft, JJ; Steer, SA; Bajaj, SP
      Structure and biology of tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    28. Stalboerger, PG; Panetta, CJ; Simari, RD; Caplice, NM
      Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    29. Broze, GJ
      Protein Z-dependent regulation of coagulation

      THROMBOSIS AND HAEMOSTASIS
    30. Hoffman, M; Monroe, DM
      A cell-based model of hemostasis

      THROMBOSIS AND HAEMOSTASIS
    31. Brown, JR; Kuter, DJ
      The effect of unfractionated vs. low molecular weight heparin on tissue factor pathway inhibitor levels in hospital inpatients

      THROMBOSIS AND HAEMOSTASIS
    32. Li, AG; Chang, ACK; Peer, GT; Wun, TC; Taylor, FB
      Recombinant tissue factor pathway inhibitor enhances the binding of factorXa to human monocytes

      THROMBOSIS AND HAEMOSTASIS
    33. Herbert, JM; Herault, JP; Bernat, A; Savi, P; Schaeffer, P; Driguez, PA; Duchaussoy, P; Petitou, M
      SR123781A, a synthetic heparin mimetic

      THROMBOSIS AND HAEMOSTASIS
    34. Tabatabai, A; Fiehler, R; Broze, GJ
      Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor

      THROMBOSIS AND HAEMOSTASIS
    35. Iakhiaev, A; Ruf, W; Rao, LVM
      The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    36. Briede, JJ; Heemskerk, JWM; van 't Veer, C; Hemker, HC; Lindhout, T
      Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets

      THROMBOSIS AND HAEMOSTASIS
    37. Rintelen, C; Yegneswaran, S; Griffin, JH
      Anticoagulant dysfunction of human Arg352Trp-activated protein C caused bydefective factor Va inactivation

      THROMBOSIS AND HAEMOSTASIS
    38. Hoekema, L; Castoldi, E; Tans, G; Girelli, D; Gemmati, D; Bernardi, F; Rosing, J
      Functional properties of factor V and factor Va encoded by the R2-gene

      THROMBOSIS AND HAEMOSTASIS
    39. Rezaie, AR; Yang, LK
      Probing the molecular basis of factor Xa specificity by mutagenesis of theserpin, antithrombin

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    40. Lin, PH; Sinha, U; Betz, A
      Antithrombin binding of low molecular weight heparins and inhibition of factor Xa

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    41. Griffon, N; Di Stasio, E
      Thermodynamics of Na+ binding to coagulation serine proteases

      BIOPHYSICAL CHEMISTRY
    42. Brophy, DF; Wazny, LD; Gehr, TWB; Comstock, TJ; Venitz, J
      Low-molecular-weight heparin administration in patients with end-stage renal disease - Author's reply

      PHARMACOTHERAPY
    43. Suzuki, M; Kobayashi, H; Tanaka, Y; Hirashima, Y; Terao, T
      Structure and function analysis of urinary trypsin inhibitor (UTI): identification of binding domains and signaling property of UTI by analysis of truncated proteins

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    44. Harrison, LM; Cordova, JL; Cappello, M
      Ancylostoma caninum anticoagulant peptide-5: immunolocalization and in vitro neutralization of a major hookworm anti-thrombotic

      MOLECULAR AND BIOCHEMICAL PARASITOLOGY
    45. Rebello, SS; Kasiewski, CJ; Wang, W; Bentley, RG; Morgan, SR; Chu, V; Colussi, D; Brown, K; Perrone, MH; Leadley, RJ
      Role of short-term inhibition of factor Xa by FXV673 in arterial passivation: A study in a chronic model of thrombosis in conscious dogs

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    46. Groth, T; Wagenknecht, W
      Anticoagulant potential of regioselective derivatized cellulose

      BIOMATERIALS
    47. Ali, F; Brown, A; Stanssens, P; Timothy, LM; Soule, HR; Pritchard, DI
      Vaccination with neutrophil inhibitory factor reduces the fecundity of thehookworm Ancylostoma ceylanicum

      PARASITE IMMUNOLOGY
    48. Sissi, C; Naggi, A; Torri, G; Palumbo, M
      Effects of sulfation on antithrombin-thrombin/factor Xa interactions in semisynthetic low molecular weight heparins

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    49. Bretschneider, E; Schror, K
      Cellular effects of factor Xa on vascular smooth muscle cells - Inhibitionby heparins?

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    50. Alban, S
      Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    51. Creasey, AA; Reinhart, K
      Tissue factor pathway inhibitor activity in severe sepsis

      CRITICAL CARE MEDICINE
    52. McLean, K; Schirm, S; Johns, A; Morser, J; Light, DR
      FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834

      THROMBOSIS RESEARCH
    53. Chu, V; Brown, K; Colussi, D; Gao, JB; Bostwick, J; Kasiewski, C; Bentley, R; Morgan, S; Guertin, K; Pauls, HW; Gong, Y; Zulli, A; Perrone, MH; Dunwiddie, CT; Leadley, RJ
      Pharmacological characterization of a novel factor Xa inhibitor, FXV673

      THROMBOSIS RESEARCH
    54. Hansen, JB; Grimsgaard, S; Huseby, NE; Sandset, PM; Bonaa, KH
      Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men

      THROMBOSIS RESEARCH
    55. Tsuruda, A; Kanno, S; Ohtani, H; Suzuki, R; Nishioka, M; Koshiyama, Y; Kurumi, M
      Effect of sepimostat mesilate on experimental venous thrombosis in rats

      THROMBOSIS RESEARCH
    56. Tsuji, R; Tatsumi, N; Hino, M; Nishioka, T; Takubo, T
      Tissue factor pathway inhibitor as a universal anticoagulant for use in clinical laboratory tests

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    57. Peterlin-Masic, L; Kikelj, D
      Arginine mimetics

      TETRAHEDRON
    58. Mischke, R; Jacobs, C
      The monitoring of heparin administration by screening tests in experimental dogs

      RESEARCH IN VETERINARY SCIENCE
    59. Fareed, J; Shaikh, T; Hoppensteadt, DA
      Antithrombin and anti-Xa agents in the control of thrombogenesis

      PHARMAZIE
    60. Eriksson, BI; Bauer, KA; Lassen, MR; Turpie, AGG
      Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

      NEW ENGLAND JOURNAL OF MEDICINE
    61. Bauer, KA; Eriksson, BI; Lassen, MR; Turpie, AGG
      Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

      NEW ENGLAND JOURNAL OF MEDICINE
    62. Turpie, AGG; Gallus, AS; Hoek, JA
      A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.

      NEW ENGLAND JOURNAL OF MEDICINE
    63. Sheehan, J; Templer, M; Gregory, M; Hanumanthaiah, R; Troyer, D; Phan, T; Thankavel, B; Jagadeeswaran, P
      Demonstration of the extrinsic coagulation pathway in teleostei: Identification of zebrafish coagulation factor VII

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    64. Mizuno, H; Fujimoto, Z; Atoda, H; Morita, T
      Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    65. Li, Z; Feiten, HJ; Chang, DL; Duetz, WA; van Beilen, JB; Witholt, B
      Preparation of (R)- and (S)-N-protected 3-hydroxypyrrolidines by hydroxylation with Sphingomonas sp HXN-200, a highly active, regio- and stereoselective, and easy to handle biocatalyst

      JOURNAL OF ORGANIC CHEMISTRY
    66. Dullweber, F; Stubbs, MT; Musil, D; Sturzebecher, J; Klebe, G
      Factorising ligand affinity: A combined thermodynamic and crystallographicstudy of trypsin and thrombin inhibition

      JOURNAL OF MOLECULAR BIOLOGY
    67. Katz, BA; Elrod, K; Luong, C; Rice, MJ; Mackman, RL; Sprengeler, PA; Spencer, J; Hataye, J; Janc, J; Link, J; Litvak, J; Rai, R; Rice, K; Sideris, S; Verner, E; Young, W
      A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site

      JOURNAL OF MOLECULAR BIOLOGY
    68. Mackman, RL; Katz, BA; Breitenbucher, JG; Hui, HC; Verner, E; Luong, C; Liu, L; Sprengeler, PA
      Exploiting subsite S1 of trypsin-like serine proteases for selectivity: Potent and selective inhibitors of urokinase-type plasminogen activator

      JOURNAL OF MEDICINAL CHEMISTRY
    69. Bungiro, RD; Greene, J; Kruglov, E; Cappello, M
      Mitigation of hookworm disease by immunization with soluble extracts of Ancylostoma ceylanicum

      JOURNAL OF INFECTIOUS DISEASES
    70. Silke, J; Vaux, DL
      Two kinds of BIR-containing protein - inhibitors of apoptosis, or requiredfor mitosis

      JOURNAL OF CELL SCIENCE
    71. Chen, CP; Hsu, CH; Su, NY; Lin, YC; Chiou, SH; Wu, SH
      Solution structure of a Kunitz-type chymotrypsin inhibitor isolated from the elapid snake Bungarus fasciatus

      JOURNAL OF BIOLOGICAL CHEMISTRY
    72. Arocas, V; Bock, SC; Raja, S; Olson, ST; Bjork, I
      Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding

      JOURNAL OF BIOLOGICAL CHEMISTRY
    73. Boskovic, DS; Bajzar, LS; Nesheim, ME
      Channeling during prothrombin activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    74. Urano, T; Ihara, H; Umemura, K; Suzuki, Y; Oike, M; Akita, S; Tsukamoto, Y; Suzuki, I; Takada, A
      The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    75. Friedrich, U; Nicolaes, GAF; Villoutreix, BO; Dahlback, B
      Secondary substrate-binding exosite in the serine protease domain of activated protein C important for cleavage at Arg-506 but not at Arg-306 in factor Va

      JOURNAL OF BIOLOGICAL CHEMISTRY
    76. Zeibdawi, AR; Pryzdial, ELG
      Mechanism of factor Va inactivation by plasmin - Loss of A2 and A3 domainsfrom a Ca2+-dependent complex of fragments bound to phospholipid

      JOURNAL OF BIOLOGICAL CHEMISTRY
    77. Brufatto, N; Nesheim, ME
      The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    78. Kalafatis, M; Mann, KG
      The role of the membrane in the inactivation of factor Va by plasmin - Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function

      JOURNAL OF BIOLOGICAL CHEMISTRY
    79. Soejima, K; Mizuguchi, J; Yuguchi, M; Nakagaki, T; Higashi, S; Iwanaga, S
      Factor VIIa modified in the 170 loop shows enhanced catalytic activity butdoes not change the zymogen-like property

      JOURNAL OF BIOLOGICAL CHEMISTRY
    80. Larsson, H; Akerud, P; Nordling, K; Raub-Segall, E; Claesson-Welsh, L; Bjork, I
      A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    81. Hembrough, TA; Ruiz, JF; Papathanassiu, AE; Green, SJ; Strickland, DK
      Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    82. Fay, PJ; Mastri, M; Koszelak, ME; Wakabayashi, H
      Cleavage of factor VIII heavy chain is required for the functional interaction of A2 subunit with factor IXa

      JOURNAL OF BIOLOGICAL CHEMISTRY
    83. Anderson, JAM; Fredenburgh, JC; Stafford, AR; Guo, YS; Hirsh, J; Ghazarossian, V; Weitz, JI
      Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    84. Bergum, PW; Cruikshank, A; Maki, SL; Kelly, CR; Ruf, W; Vlasuk, GP
      Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2

      JOURNAL OF BIOLOGICAL CHEMISTRY
    85. Briede, JJ; Tans, G; Willems, GM; Hemker, HC; Lindhout, T
      Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent

      JOURNAL OF BIOLOGICAL CHEMISTRY
    86. Salzet, M
      Anticoagulants and inhibitors of platelet aggregation derived from leeches

      FEBS LETTERS
    87. Hayashi, M; Hamada, A; Okaya, Y; Wakitani, K; Aisaka, K
      Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factorXa in vitro and in vivo

      EUROPEAN JOURNAL OF PHARMACOLOGY
    88. Hayashi, M; Matsuo, A; Nakamoto, H; Aisaka, K
      Antithrombotic effects of a synthetic inhibitor of activated factor X, JTV-803, in animals

      EUROPEAN JOURNAL OF PHARMACOLOGY
    89. Weitz, JI; Hirsh, J
      New anticoagulant drugs

      CHEST
    90. Nishida, H; Miyazaki, Y; Kitamura, Y; Ohashi, M; Matsusue, T; Okamoto, A; Hosaka, Y; Ohnishi, S; Mochizuki, H
      Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor

      CHEMICAL & PHARMACEUTICAL BULLETIN
    91. Rebello, SS; Bentley, RG; Morgan, SR; Kasiewski, CJ; Chu, V; Perrone, MH; Leadley, RJ
      Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis

      BRITISH JOURNAL OF PHARMACOLOGY
    92. Adams, MJ; Donohoe, S; Mackie, IJ; Machin, SJ
      Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome

      BRITISH JOURNAL OF HAEMATOLOGY
    93. Simmelink, MJA; Horbach, DA; Derksen, RHWM; Meijers, JCM; Bevers, EM; Willems, GM; De Groot, PG
      Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces

      BRITISH JOURNAL OF HAEMATOLOGY
    94. White, B; Perry, D
      Acquired antithrombin deficiency in sepsis

      BRITISH JOURNAL OF HAEMATOLOGY
    95. Caplice, NM; Panetta, C; Peterson, TE; Kleppe, LS; Mueske, CS; Kostner, GM; Broze, GJ; Simari, RD
      Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis

      BLOOD
    96. Deguchi, H; Fernandez, JA; Pabinger, I; Heit, JA; Griffin, JH
      Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway

      BLOOD
    97. Shimada, H; Kasakura, S; Shiotani, M; Nakamura, K; Ikeuchi, M; Hoshino, T; Komatsu, T; Ihara, Y; Sohma, M; Maeda, Y; Matsuura, R; Nakamura, S; Hine, C; Ohkura, N; Kato, H
      Hypocoagulable state of human preovulatory ovarian follicular fluid: Role of sulfated proteoglycan and tissue factor pathway inhibitor in the fluid

      BIOLOGY OF REPRODUCTION
    98. Baskova, IP; Zavalova, LL
      Proteinase inhibitors from the medicinal leech Hirudo medicinalis

      BIOCHEMISTRY-MOSCOW
    99. Sere, KM; Janssen, MP; Willems, GM; Tans, G; Rosing, J; Hackeng, TM
      Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity

      BIOCHEMISTRY
    100. Srivastava, A; Quinn-Allen, MA; Kim, SW; Kane, WH; Lentz, BR
      Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor V-a

      BIOCHEMISTRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 08:26:03